Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
 
Sponsors and Collaborators
National Cancer Institute (NCI)
 
Contact
NCI Referral Office    
1-888-NCI-1937
 
ClinicalTrials.gov Identifier
NCT00923130